Kevin Neil Dack

Person

Kent, GB

People

Patents Grantslast 30 patents

Information Patent Grant
4-(biphen-3-yl)-1H-pyrazolo[3,4-c]pyridazine derivatives of formula...
- Patent number 10,538,523
- Issue date Jan 21, 2020
- Pfizer Limited
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alkoxy-substituted 2-aminopyridines as ALK inhibitors
- Patent number 8,916,593
- Issue date Dec 23, 2014
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidines
- Patent number 8,278,343
- Issue date Oct 2, 2012
- Pfizer Inc.
- Kevin N. Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors
- Patent number 8,097,621
- Issue date Jan 17, 2012
- Pfizer Inc.
- Andrew Simon Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
- Patent number 7,572,799
- Issue date Aug 11, 2009
- Pfizer Inc.
- Andrew Simon Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful in therapy
- Patent number 7,482,375
- Issue date Jan 27, 2009
- Pfizer Inc.
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1H-pyrazoles useful in therapy
- Patent number 7,425,569
- Issue date Sep 16, 2008
- Pfizer Inc.
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1H-pyrazoles useful in therapy
- Patent number 7,309,712
- Issue date Dec 18, 2007
- Pfizer Limited
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds useful in therapy
- Patent number 7,084,145
- Issue date Aug 1, 2006
- Pfizer Inc.
- Robert Duncan Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceuticals
- Patent number 7,045,653
- Issue date May 16, 2006
- Pfizer, Inc.
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutically active compounds
- Patent number 6,794,387
- Issue date Sep 21, 2004
- Pfizer Inc.
- Charlotte Moira Norfor Allerton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metalloprotease inhibitors
- Patent number 6,511,993
- Issue date Jan 28, 2003
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
- Patent number 6,495,568
- Issue date Dec 17, 2002
- Warner-Lambert Company
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
- Patent number 6,387,931
- Issue date May 14, 2002
- Pfizer Inc.
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives useful as endothelin receptor antagonists
- Patent number 6,384,070
- Issue date May 7, 2002
- Pfizer Inc.
- David James Rawson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease inhibitors
- Patent number 6,350,907
- Issue date Feb 26, 2002
- Pfizer Inc.
- Michael Jonathan Fray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives useful as endothelin receptor antagonists
- Patent number 6,306,852
- Issue date Oct 23, 2001
- Pfizer Inc.
- David James Rawson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives useful in therapy
- Patent number 6,211,223
- Issue date Apr 3, 2001
- Pfizer Inc.
- Stephen Challenger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives useful as endothelin receptor antagonists
- Patent number 6,136,843
- Issue date Oct 24, 2000
- Pfizer Inc.
- David James Rawson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeut...
- Patent number 6,090,852
- Issue date Jul 18, 2000
- Pfizer Inc.
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene derivatives useful in therapy
- Patent number 6,040,309
- Issue date Mar 21, 2000
- Pfizer, Inc.
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives useful as endothelin receptor antagonists
- Patent number 6,017,945
- Issue date Jan 25, 2000
- Pfizer Inc.
- David James Rawson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives thromboxane A2 antagonists
- Patent number 5,744,488
- Issue date Apr 28, 1998
- Pfizer Inc.
- Peter Edward Cross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine- and imidazole-derived agents for cardiovascular diseases
- Patent number 5,705,523
- Issue date Jan 6, 1998
- Pfizer Inc.
- Roger Peter Dickinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzenealkanoic acids for cardiovascular diseases
- Patent number 5,618,941
- Issue date Apr 8, 1997
- Pfizer Inc.
- Roger P. Dickinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine derived agents for cardiovascular diseases
- Patent number 5,457,118
- Issue date Oct 10, 1995
- Pfizer Inc.
- Roger P. Dickinson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20180346470
- Publication date Dec 6, 2018
- PFIZER LIMITED
- KEVIN NEIL DACK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES
- Publication number 20130196952
- Publication date Aug 1, 2013
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azetidines As EP2 Antagonists
- Publication number 20100256109
- Publication date Oct 7, 2010
- Sarah Elizabeth Skerratt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolidines
- Publication number 20100120793
- Publication date May 13, 2010
- Kevin N. Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Pharmaceuticals
- Publication number 20090247539
- Publication date Oct 1, 2009
- Pfizer Inc.
- Andrew Simon Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Useful in Therapy
- Publication number 20090099209
- Publication date Apr 16, 2009
- Pfizer Inc.
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azetidines
- Publication number 20080280877
- Publication date Nov 13, 2008
- Pfizer Inc.
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Useful In Therapy
- Publication number 20080096950
- Publication date Apr 24, 2008
- Karl Richard Gibson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-Pyrazoles Useful In Therapy
- Publication number 20080085919
- Publication date Apr 10, 2008
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds useful in therapy
- Publication number 20070105909
- Publication date May 10, 2007
- Pfizer Inc.
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds useful in therapy
- Publication number 20060241125
- Publication date Oct 26, 2006
- Paul Anthony Bradley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pharmaceuticals
- Publication number 20050245544
- Publication date Nov 3, 2005
- Andrew Simon Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pharmaceuticals
- Publication number 20050075392
- Publication date Apr 7, 2005
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Composition for the treatment of damaged tissue
- Publication number 20050026836
- Publication date Feb 3, 2005
- Kevin Neil Dack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Triazole compounds useful in therapy
- Publication number 20040162278
- Publication date Aug 19, 2004
- Pfizer Inc.
- Robert Duncan Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pharmaceuticals
- Publication number 20040138274
- Publication date Jul 15, 2004
- Kevin Neil Dack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Composition for the treatment of damaged tissue
- Publication number 20030199440
- Publication date Oct 23, 2003
- Pfizer Inc.
- Kevin Neil Dack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutically active compounds
- Publication number 20020177599
- Publication date Nov 28, 2002
- Charlotte Moira Norfor Allerton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indole derivatives useful as endothelin receptor antagonists
- Publication number 20010014677
- Publication date Aug 16, 2001
- David James Rawson
- C07 - ORGANIC CHEMISTRY

Kevin Neil Dack

Person

Patents Grantslast 30 patents

4-(biphen-3-yl)-1H-pyrazolo[3,4-c]pyridazine derivatives of formula...

Alkoxy-substituted 2-aminopyridines as ALK inhibitors

Pyrrolidines

Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors

Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors

Compounds useful in therapy

1H-pyrazoles useful in therapy

1H-pyrazoles useful in therapy

Triazole compounds useful in therapy

Pharmaceuticals

Pharmaceutically active compounds

Metalloprotease inhibitors

Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors

Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors

Indole derivatives useful as endothelin receptor antagonists

Matrix metalloprotease inhibitors

Indole derivatives useful as endothelin receptor antagonists

Indole derivatives useful in therapy

Indole derivatives useful as endothelin receptor antagonists

Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeut...

Benzothiophene derivatives useful in therapy

Indole derivatives useful as endothelin receptor antagonists

Indole derivatives thromboxane A2 antagonists

Pyridine- and imidazole-derived agents for cardiovascular diseases

Benzenealkanoic acids for cardiovascular diseases

Pyridine derived agents for cardiovascular diseases

Patents Applicationslast 30 patents

CHEMICAL COMPOUNDS

HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES

Azetidines As EP2 Antagonists

Pyrrolidines

Novel Pharmaceuticals

Compounds Useful in Therapy

Azetidines

Compounds Useful In Therapy

1H-Pyrazoles Useful In Therapy

Compounds useful in therapy

Compounds useful in therapy

Novel pharmaceuticals

Novel pharmaceuticals

Composition for the treatment of damaged tissue

Triazole compounds useful in therapy

Novel pharmaceuticals

Composition for the treatment of damaged tissue

Pharmaceutically active compounds

Indole derivatives useful as endothelin receptor antagonists